Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus.
about
Fluorescent and Bioluminescent Reporter MyxovirusesIllumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomyMyogenic differentiation in atrium-derived adult cardiac pluripotent cells and the transcriptional regulation of GATA4 and myogenin on ANP promoterEnhanced anti-HIV-1 activity of CC-chemokine LD78β, a non-allelic variant of MIP-1α/LD78αParamyxovirus replication and pathogenesis. Reverse genetics transforms understanding.Paramyxovirus reverse genetics is coming of age.The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replicationRescue of mumps virus from cDNA.A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression.Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the fusion protein gene.Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5.Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice.Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine.The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down-regulating viral RNA synthesisAdding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression.An efficient and versatile mammalian viral vector system for major histocompatibility complex class I/peptide complexesProline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen.Sendai virus vectors as an emerging negative-strand RNA viral vector system.Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging studyRNA virus vectors: where are we and where do we need to go?TMPRSS2 is an activating protease for respiratory parainfluenza viruses.Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost RegimensRNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.Vectorology and factor delivery in induced pluripotent stem cell reprogramming.RNA-based viral vectors.Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vectorRescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulenceConstruction of a minigenome rescue system for Newcastle disease virus strain Italien.Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins.A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreadingGeneration of measles virus with a segmented RNA genome.Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties.Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector.Efficient gene transfer to airway epithelium using recombinant Sendai virus.Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication.Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis.Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4- but not CCR-5-dependent fusion.Large quantity production with extreme convenience of human SDF-1alpha and SDF-1beta by a Sendai virus vector.
P2860
Q26741398-D412F3E7-71B4-41F7-8862-4B6124CDDE46Q27349385-A81CEBB7-BCDC-4ADF-B4D3-0712F5A49975Q28572161-29523AFA-F26B-4787-B647-299A1A2CE3E1Q29012475-34CF9D5B-B706-4C8C-BA10-D4BF439CBB0FQ33673962-7E9EC8FC-14B3-476B-9F09-1D392A072856Q33755770-1EB50FC9-D9E0-4057-9F0C-28B488983E0DQ33783140-A4E669FD-CB4B-409D-B79E-17421BD49246Q33804946-320D0159-5734-43DF-8356-1492584D92F6Q33808044-BB5516A0-2DA0-474E-8AF0-7894DEDF7575Q33822967-6BD34EC1-78C5-47E1-93D7-9FEF24473096Q33838860-7CC601A5-21B1-4B1A-BC98-A7D5B846B158Q33845383-30C40ECF-3F94-45CF-B47B-240A83D44731Q34033280-E94859B8-8D94-4F64-9629-EB4FF7738FB7Q34341904-0692BA14-1E06-481C-8342-65ECB14DABC5Q34343430-D8C3B760-ED3F-4DC5-B517-F6123C266AE2Q34359447-49774DA7-0EBD-43CC-BBCF-66AED395CE68Q34464175-618B789D-C9D1-40C3-B064-9A9809E88DE1Q35161890-E5E1D63E-3016-4FC5-BFCE-F51CB1B94E58Q35487966-8F106E0F-2895-406E-9CB1-1F90C5F7BB19Q36080373-14597C2B-2B15-4DC7-96C1-648072B37F95Q37252750-DA822BBA-F157-4DBC-B1B8-A931906870E9Q37400834-1D92D071-AF30-4DE9-B7AF-89736AFCDD53Q37492711-7D2AAE6F-4FE0-4648-BF16-2D818C4390E8Q37578465-4CB0C50F-A833-4B08-BC21-EF9DD65B8606Q38121503-6466D217-BDD4-4CFB-9366-EE06B6244714Q38195650-5D564886-355E-4979-BA73-9773E14EB10FQ38266413-A8B96D41-39EF-4965-8830-4C1DEE876E25Q39593656-17B9A1D6-56B6-4B6C-82A3-2FF3CCF20C0EQ39594181-79868360-DA61-452F-B91F-8E37F75C1CD8Q39612067-06190E76-5145-4076-B5C2-E406F27C5BC5Q39733557-76B59A28-5DBB-45FD-8B90-653074107257Q39752502-8A6919E8-1C40-4F47-8671-333502CD0F2FQ40293099-5AB4CE2C-80B0-48D2-B28A-69C4147F92A2Q40512123-0970E387-E9BF-4C90-96DD-15371A8ED6D0Q40783262-E0CBBF8B-70D0-49CB-83B3-EC5CDEF3ACFEQ40856925-8A283415-FB96-4510-AF96-AE7C620E5A8DQ40934160-8CE0D597-8E44-4358-B36A-FAA17EE5F715Q41038886-EFF7508F-DFEF-4F4D-A924-A8F765CEF709Q41040646-81B8BA07-0C7C-4B5C-914D-36D0F6FA2C98Q41051587-A3A5331A-2FA3-41DE-BC5C-2DE1C1CA49CC
P2860
Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Creation of an infectious reco ...... m the 3' proximal first locus.
@en
type
label
Creation of an infectious reco ...... m the 3' proximal first locus.
@en
prefLabel
Creation of an infectious reco ...... m the 3' proximal first locus.
@en
P2093
P1476
Creation of an infectious reco ...... m the 3' proximal first locus.
@en
P2093
P304
P356
10.1099/0022-1317-78-11-2813
P407
P478
78 ( Pt 11)
P577
1997-11-01T00:00:00Z